Incidence of Adverse Effects and Discontinuation Rate between Patients Receiving 250 Micrograms and 500 Micrograms of Roflumilast: A Comparative Study.
Hyonsoo JooDeokjae HanJae Ha LeeChin Kook RheePublished in: Tuberculosis and respiratory diseases (2018)
There was a lower incidence of adverse effects and discontinuation among patients treated with 250 μg compared with 500 μg dose. Further studies regarding the optimal dose of roflumilast are required.
Keyphrases